SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?


To: sjemmeri who wrote (4537)12/16/2005 9:38:38 AM
From: scaram(o)ucheRead Replies (1) | Respond to of 4974
 
>> cited changing market conditions <<

Hmmmmmmmm.............. I'd cite a lousy roadshow?

:-)

Thanks, Steve.

Rick



To: sjemmeri who wrote (4537)12/21/2005 7:43:53 AM
From: sjemmeriRead Replies (1) | Respond to of 4974
 
12/20/2005 PWCK
Drug maker Prestwick Pharmaceuticals withdraws IPO
Prestwick Pharmaceuticals, a developer of small molecule drugs for the treatment of chronic illnesses of the central nervous system, withdrew its IPO plans due to market conditions Tuesday evening. UBS Investment Bank, Deutsche Bank and CIBC World Markets were listed as the underwriters on the deal.